Low-dose Aspirin Use to Prevent Colorectal Cancer and Cardiovascular Disease
Document Type
Peer-Reviewed Article
Publication Date
1-2023
Abstract
The American Cancer Society (ACS) estimates 151,030 new cases and 52,580 deaths from colorectal cancer (CRC) in 2022.
The gastroenterology nurse sees many patients for CRC screening and a variety of gastroenteric conditions. This population may have been started on low-dose aspirin for CVD prevention or CRC chemoprevention. The updated and more restricted USPSTF (2022) recommendations should be used to guide their treatment.
DOI
10.1097/SGA.0000000000000680
PMID
36624567
Recommended Citation
Morrow, L., & Greenwald, B. (2023). Low-dose aspirin use to prevent colorectal cancer and cardiovascular disease. Gastroenterology Nursing, 46(1), 76-77. Doi.org/10.1097/SGA.0000000000000680
Publication
Gastroenterology Nursing
Publisher
Wolters Kluwer
